Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

(NYSE:HIMS) SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men’s health, offering access to innovative, affordable, and personalized treatment plans for low testosterone. An estimated twenty million men in the U.S. struggle with low testosterone1 2. Left untreated, it can drain energy, dull mood and sexual desire, and raise risks of heart disease, diabetes, and cancer. Treatment can restore